Changes in Airway Dimensions Following Non-extraction Clear Aligner Therapy in Adult Patients with Mild-to-moderate Crowding.

AIM AND OBJECTIVE: This retrospective study aimed to assess changes in airway dimensions with non-extraction clear-aligner-therapy (NE-CAT) in adult patients with mild-to-moderate crowding. MATERIALS AND METHODS: Cone-beam computed tomographic images were evaluated for 24 adults (16 females and 8 males) with mild-to-moderate crowding, and Class I or mild skeletal Class II malocclusion before and after NE-CAT. Cross-sectional and volumetric airway measurements were performed at the level of the nasal cavity, upper pharyngeal airway space (UAS), and lower pharyngeal airway space (LAS). The Frankfort-mandibular plane angle (FMA), point A-nasion-point B (ANB) angle, and intermolar width were measured. A paired t-test was used to assess changes in airway measurements. Linear regression analyses were performed to identify predictors of the pharyngeal airway volume change at the levels of the UAS and LAS. RESULTS: There was a significant decrease (p = 0.004) in UAS mean volume (486.63± 752.73 mm3), LAS mean volume (p = 0.006), and cross-sectional airway area (p = 0.022) (1536.92± 2512.02 mm3 and 34.66± 69.35 mm2, respectively) with NE-CAT. The mean airway volume of the nasal cavity, mean cross-sectional airway areas of the nasal cavity and UAS, and mean minimum cross-sectional pharyngeal airway area did not change significantly with NE-CAT. Changes in pharyngeal airway volume were not significantly associated with patients' age, gender, treatment duration, pretreatment ANB angle, and changes in FMA and maxillary first intermolar width with NE-CAT. CONCLUSION: Significant changes in the pharyngeal airway dimensions of the UAS and LAS with NE-CAT in adult patients with mild-to-moderate crowding were identified. CLINICAL SIGNIFICANCE: The results of the present study show that NE-CAT is not associated with an improvement in airway dimensions in adults with mild to moderate crowding.

Ethanol Modulation is Quantitatively Determined by the Transmembrane Domain of Human α1 Glycine Receptors.

BACKGROUND: Mutagenesis and labeling studies have identified amino acids from the human α1 glycine receptor (GlyR) extracellular, transmembrane (TM), and intracellular domains in mediating ethanol (EtOH) potentiation. However, limited high-resolution structural data for physiologically relevant receptors in this Cys-loop receptor superfamily have made pinpointing the critical amino acids difficult. Homologous ion channels from lower organisms provide conserved models for structural and functional properties of Cys-loop receptors. We previously demonstrated that a single amino acid variant of the Gloeobacter violaceus ligand-gated ion channel (GLIC) produced EtOH and anesthetic sensitivity similar to that of GlyRs and provided crystallographic evidence for EtOH binding to GLIC. METHODS: We directly compared EtOH modulation of the α1 GlyR and GLIC to a chimera containing the TM domain from human α1 GlyRs and the ligand-binding domain of GLIC using 2-electrode voltage-clamp electrophysiology of receptors expressed in Xenopus laevis oocytes. RESULTS: EtOH potentiated α1 GlyRs in a concentration-dependent manner in the presence of zinc-chelating agents, but did not potentiate GLIC at pharmacologically relevant concentrations. The GLIC/GlyR chimera recapitulated the EtOH potentiation of GlyRs, without apparent sensitivity to zinc chelation. For chimera expression in oocytes, it was essential to suppress leakage current by adding 50 µM picrotoxin to the media, a technique that may have applications in expression of other ion channels. CONCLUSIONS: Our results are consistent with a TM mechanism of EtOH modulation in Cys-loop receptors. This work highlights the relevance of bacterial homologs as valuable model systems for studying ion channel function of human receptors and demonstrates the modularity of these channels across species.